RACHEL BYRNES: Open Payments
NPI 1578990800 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| ABBVIE INC. | 2 | $32 |
| Dexcom, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $14 |
Products named: JARDIANCE, QULIPTA, Dexcom G6 Transmitter, FREESTYLE LIBRE, Kerendia, Rybelsus.
Industry payments across TX — which companies pay providers there.
